Inactivated meningococci and pertussis bacteria are immunogenic and act as mucosal adjuvants for a nasal inactivated influenza virus vaccine

This publication has 36 references indexed in Scilit:

• Epithelial M Cells: Gateways for Mucosal Infection and Immunization
  Cell, 1996
• Antibody responses in volunteers induced by nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin
  Vaccine, 1996
• Intranasal immunization of mice against influenza with synthetic peptides anchored to proteosomes
  Vaccine, 1995
• Human immune responses to influenza virus vaccines administered by systemic or mucosal routes
  Vaccine, 1995
• New strategies for using mucosal vaccination to achieve more effective immunization
  Vaccine, 1994
• Immunopotentiation of local and systemic humoral immune responses by ISCOMs, liposomes and FCA: role in protection against influenza A in mice
  Vaccine, 1993
• Superior cross‐protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine
  European Journal of Immunology, 1992
• Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination
  Vaccine, 1990
• Cross‐protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity
  European Journal of Immunology, 1984
• Interaction of Neisseria meningitidis with Human Nasopharyngeal Mucosa: Attachment and Entry into Columnar Epithelial Cells
  The Journal of Infectious Diseases, 1983